Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ferritin nanoparticles displaying rift valley fever virus glycoprotein elicit potent dendritic cell activation in vitro.

Virology journal·2026
Same author

An improved CRISPR-Cas9 protein-based method for knocking out insect Sf9 cell genes.

Applied microbiology and biotechnology·2026
Same author

Enhancing gene therapy vectors manufacturing: CEBPA as a master regulator of rAAV biogenesis.

Journal of biological engineering·2026
Same author

Site-directed tyrosinase conjugation on engineered ferritin retains immune recognition.

Scientific reports·2025
Same author

Streamlined purification of ADDomer nanoparticles for scalable biomanufacturing.

Journal of biological engineering·2025
Same author

Developing a robust and scalable platform for AAV8 production.

Journal of biotechnology·2025
Same journal

RETRACTED: Meligy et al. Therapeutic Potential of Mesenchymal Stem Cells Versus Omega n - 3 Polyunsaturated Fatty Acids on Gentamicin-Induced Cardiac Degeneration. <i>Pharmaceutics</i> 2022, <i>14</i>, 1322.

Pharmaceutics·2026
Same journal

Correction: Mohite et al. Bioactive Compound-Fortified Nanomedicine in the Modulation of Reactive Oxygen Species and Enhancement of the Wound Healing Process: A Review. <i>Pharmaceutics</i> 2025, <i>17</i>, 855.

Pharmaceutics·2026
Same journal

Metal Nanoparticle-Reinforced Hydrogels Applied in the Inhibition of Clinical Pathogens: Structural Features, Mechanisms, and Biomedical Prospects.

Pharmaceutics·2026
Same journal

Development and Evaluation of a Physiologically Based Pharmacokinetic Model for Cipepofol Across Diverse Clinical Populations.

Pharmaceutics·2026
Same journal

Artificial Intelligence in Nanopharmaceutical Development: From Predictive Design to Clinical Translation.

Pharmaceutics·2026
Same journal

Textilinin-1, a Snake Venom-Derived Kunitz-Type Protease Inhibitor, Accelerates Wound Healing Through Anti-Inflammatory, Antibacterial, and Pro-Regenerative Activities.

Pharmaceutics·2026
See all related articles

Related Experiment Video

Updated: Oct 15, 2025

Synthesis of Cationized Magnetoferritin for Ultra-fast Magnetization of Cells
10:23

Synthesis of Cationized Magnetoferritin for Ultra-fast Magnetization of Cells

Published on: December 13, 2016

10.2K

Functionalizing Ferritin Nanoparticles for Vaccine Development.

Margarida Q Rodrigues1,2, Paula M Alves1,2, António Roldão1,2

  • 1iBET, Instituto de Biologia Experimental e Tecnológica, Apartado 12, 2781-901 Oeiras, Portugal.

Pharmaceutics
|October 23, 2021
PubMed
Summary
This summary is machine-generated.

Ferritin-based vaccines show promise for safety and immunogenicity, with candidates in clinical trials. Overcoming manufacturing challenges is key to making these novel therapeutics widely available.

Keywords:
ferritin nanoparticlesgenetic fusionmodular assemblyrecombinant expressionsurface decorationvaccines

More Related Videos

Surface Functionalization of Hepatitis E Virus Nanoparticles Using Chemical Conjugation Methods
09:12

Surface Functionalization of Hepatitis E Virus Nanoparticles Using Chemical Conjugation Methods

Published on: May 11, 2018

7.0K
Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation
10:58

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation

Published on: August 21, 2019

7.7K

Related Experiment Videos

Last Updated: Oct 15, 2025

Synthesis of Cationized Magnetoferritin for Ultra-fast Magnetization of Cells
10:23

Synthesis of Cationized Magnetoferritin for Ultra-fast Magnetization of Cells

Published on: December 13, 2016

10.2K
Surface Functionalization of Hepatitis E Virus Nanoparticles Using Chemical Conjugation Methods
09:12

Surface Functionalization of Hepatitis E Virus Nanoparticles Using Chemical Conjugation Methods

Published on: May 11, 2018

7.0K
Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation
10:58

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation

Published on: August 21, 2019

7.7K

Area of Science:

  • Biotechnology
  • Vaccinology
  • Nanotechnology

Background:

  • Growing interest in ferritin-based vaccines due to demonstrated safety and immunogenicity.
  • Clinical trials are underway for ferritin-based vaccine candidates targeting influenza, Epstein-Barr, and SARS-CoV-2 viruses.

Purpose of the Study:

  • To review the foundational elements of experimental ferritin-based vaccine formulation.
  • To discuss novel bioengineering strategies for ferritin nanoparticle functionalization.
  • To compare upstream/downstream processing approaches for vaccine production and efficacy.

Main Methods:

  • Presentation of design, production, and purification strategies for ferritin-based vaccines.
  • Discussion of modular assembly for functionalizing ferritin nanoparticles, circumventing genetic fusion issues.
  • Comparison of various upstream and downstream bioprocessing techniques.

Main Results:

  • Ferritin nanoparticles are emerging as viable platforms for vaccine development.
  • Bioengineering strategies offer solutions to challenges in antigen presentation and particle assembly.
  • Standardization of production bioprocesses is crucial for reproducibility and availability.

Conclusions:

  • Ferritin-based vaccines represent a promising vaccine platform with ongoing clinical development.
  • Advances in bioengineering and bioprocessing are addressing manufacturing hurdles.
  • Further research and standardization are needed to facilitate clinical translation and accessibility.